NASDAQ · Medical - Devices

HeartSciences Inc. (HSCS) Stock

$3.18 +4.61% NASDAQ: HSCS Healthcare

Valuation

MetricValue
Price$3.18
Market Cap$6.87M
P/E Ratio-1.36
P/B Ratio-7.87
P/S Ratio2083.52
EPS (TTM)$-9.34
52-Week High$5.25
52-Week Low$1.63
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-816.25%
ROA-274.52%
ROCE499.92%
Gross Margin-10.60%
Operating Margin-899.40%
Net Margin-14.16%
Debt/Equity-1.97
Current Ratio0.50

Annual Financials (USD)

Metric20222023202420252026
Revenue$0$0$0$0$0
Operating Profit$-5.0M$-6.0M$-6.0M$-8.0M$-8.0M
Net Profit$-5.0M$-6.0M$-7.0M$-9.0M$-9.0M
EPS$-145.48$-79.92$-18.74$-9.34$-3.48
Op Margin-32765.6%-118698.3%-33902.0%-192013.1%-194787.4%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$2.0M$3.0M$10.0M$4.0M$5.3B
Total Liabilities$8.0M$3.0M$2.0M$4.0M$5.0B
Cash$1.0M$2.0M$6.0M$1.0M$1.7B
Borrowings$6.0M$2.0M$1.0M$3.0M$3.9B

Latest News

Zcash Miner Fortitude Merging with HeartSciences to Go Public Exec Edge · Jun 23, 2026 Top Midday Gainers MT Newswires · Jun 23, 2026 BC-Most Active Stocks Associated Press · Jun 23, 2026 HeartSciences to Merge With Digital Asset Mining Platform Fortitude; Shares Rise Pre-Bell MT Newswires · Jun 23, 2026 Fortitude and HeartSciences (Nasdaq: HSCS) Announce Business Combination, Aiming to Bring a Leading Vertically-Integrated Zcash Mining Platform to the Public Markets Business Wire · Jun 23, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$-4.0M$-6.0M$-6.0M$-7.0M$-7.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$1.0M$0$0$0
Net Cash Flow$0$1.0M$4.0M$-5.0M$1.0M
Free Cash Flow$-4.0M$-6.0M$-6.0M$-7.0M$-7.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA1.74
FCF Yield-14066.03%
Quick Ratio-71.42
Interest Coverage-11.78
Return 1Y-35.68%
Return 3Y-97.31%
Return 5Y—

Ownership

Insiders Held23.24%
Institutions Held6.56%
Institutions Float Held8.54%
Institutional HolderSharesReport Date
DRW Securities, LLC76,4502026-03-31
TFB Advisors LLC29,7402026-03-31
Geode Capital Management, LLC28,9382026-03-31
Astoria Strategic Wealth, Inc.18,9272026-03-31
Vanguard Capital Management LLC17,9682026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About HeartSciences Inc.

HeartSciences Inc. is led by CEO Andrew Simpson, employs 15 people, headquartered in US, publicly traded since 2022.

HeartSciences Inc. (HSCS) stock trades at $3.18 with a market capitalization of $6.87M. The stock is valued at a price-to-earnings (P/E) ratio of -1.36, price-to-book of -7.87, price-to-sales of 2083.52. Over the past 52 weeks the stock has ranged between $1.63 and $5.25, and currently trades 39.4% below its 52-week high.

On profitability, HeartSciences Inc. generates a return on equity (ROE) of -816.25%, return on capital employed of 499.92%, an operating margin of -899.40%, a net profit margin of -14.16%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides